Ligand Pharmaceuticals And 2 Other Stocks That May Be Trading At An Estimated Discount [Yahoo! Finance]
Ligand Pharmaceuticals Incorporated (LGND)
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.ligand.com
Company Research
Source: Yahoo! Finance
In this environment, identifying stocks that may be trading at an estimated discount can provide opportunities for investors seeking value amidst a generally rising market. Top 10 Undervalued Stocks Based On Cash Flows In The United States Name Current Price Fair Value (Est) Discount (Est) Meridian Holdings (MRDN) Golar LNG (GLNG) Glaukos (GKOS) First Busey (BUSE) Coastal Financial (CCB) Caris Life Sciences (CAI) Capital One Financial (COF) Cadre Holdings (CDRE) BioHarvest Sciences (BHST) Alnylam Pharmaceuticals (ALNY) Click here to see the full list of 146 stocks from our Undervalued US Stocks Based On Cash Flows screener. Here's a peek at a few of the choices from the screener. Ligand Pharmaceuticals Overview: Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that develops and licenses biopharmaceutical assets globally, with a market cap of approximately $4.63 billion. Operations: The company's revenue primarily comes from the
Show less
Read more
Impact Snapshot
Event Time:
LGND
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LGND alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LGND alerts
High impacting Ligand Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
LGND
News
- Ligand Pharmaceuticals (LGND) had its price target raised by HC Wainwright from $243.00 to $289.00. They now have a "buy" rating on the stock.MarketBeat
- LGND: XOMA Buy Adds 100+ Assets [Yahoo! Finance]Yahoo! Finance
- Ligand Pharmaceuticals (LGND) had its price target raised by Royal Bank Of Canada from $235.00 to $252.00. They now have an "outperform" rating on the stock.MarketBeat
- Ligand Pharmaceuticals to Buy XOMA Royalty for $39/Share, Lifts 2026 Guidance and EPS Outlook [Yahoo! Finance]Yahoo! Finance
- ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty CorporationPR Newswire
LGND
Earnings
- 2/26/26 - Beat
LGND
Sec Filings
- 4/28/26 - Form DEFA14A
- 4/27/26 - Form DEFA14A
- 4/27/26 - Form 8-K
- LGND's page on the SEC website